In 2013, the National Cancer Institute spent an estimated $101.9 million dollars on pancreatic cancer research. This represented a mere 2.1% of the NCI’s $4.8 billion cancer research budget for that year. This nominal public support makes the private funding of organizations like the Rolfe Foundation all the more important.
According to the American Cancer Society, pancreatic cancer is one of the few cancers for which survival rates have not improved substantially during the last 40 years. The Rolfe Pancreatic Cancer Foundation aims to change that. Donor support is at the root of all of the Rolfe Pancreatic Cancer Foundation’s endeavors. Our efforts into early detection pancreatic cancer research are made possible because of donors like you.
If you're already a donor; thank you! If not, consider joining our family of supporters, be a catalyst for change.